• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Syra Health Selected for $5.8 Million Indiana Child Mental Health Program

    5/27/25 8:55:00 AM ET
    $SYRA
    Diversified Commercial Services
    Consumer Discretionary
    Get the next $SYRA alert in real time by email

    CARMEL, Ind., May 27, 2025 /PRNewswire/ -- Syra Health Corp. (OTCQB:SYRA) ("Syra Health" or the "Company"), a healthcare technology company dedicated to powering better health through innovative technology products and services, announced today that the Indiana Department of Administration in collaboration with the Family and Social Services Administration/Division of Mental Health and Addiction has recommended Syra Health for contract negotiations to implement Indiana's Child Mental Health Wraparound Access Site. The contract is valued at $5.8 million over three years, with an optional one-year extension. Syra has committed to subcontracting 23.5% of the total contract value to other Indiana-based companies. Revenue related to this contract is expected to be recognized later in the year, following final contract execution.

    Syra Health, Powering Better Health (PRNewsfoto/Syra Health)

    "Through this partnership, the state of Indiana is investing in Syra Health's proven ability to deliver comprehensive, outcome-driven health solutions," said Dr. Deepika Vuppalanchi, interim CEO and co-founder of Syra Health. "We bring an integrated approach that combines public health expertise, data analytics, and mental health support—ensuring programs are not only implemented, but deliver measurable impact."

    Indiana-based Syra Health has a track record of executing complex health initiatives for state and local governments, including work with Indiana's Department of Child Services and multiple agencies nationwide.

    Syra Health will serve as the statewide access point for families and providers navigating Indiana's Child Mental Health Wraparound program. This initiative is a key part of the state's broader strategy to strengthen care coordination and improve mental health outcomes for children across the state.

    About Syra Health

    Syra Health is a healthcare technology company that powers better health in critical areas such as mental health, population health, and the healthcare workforce. The company's leading-edge technology products and innovative services focus on prevention, access, and affordability. With a commitment to improving health, Syra Health is advancing healthcare solutions nationwide and around the world. For more information, please visit www.syrahealth.com.

    Forward-Looking Statements

    Statements in this press release about future expectations, plans, and prospects, as well as any other statements regarding matters that are not historical facts, may constitute "forward-looking statements." These statements include but are not limited to, statements relating to the expected use of proceeds, the Company's operations and business strategy, and the Company's expected financial results. The words "anticipate," "believe," "continue," "could," "estimate," "expect," "intend," "may," "plan," "potential," "predict," "project," "should," "target," "will," "would" and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. The forward-looking statements contained in this press release are based on management's current expectations and are subject to substantial risks, uncertainty, and changes in circumstances. Investors should read the risk factors set forth in our Form 10-K for the year ended December 31, 2024, and other periodic reports filed with the Securities and Exchange Commission. Any forward-looking statements contained in this press release speak only as of the date hereof, and, except as required by federal securities laws, the Company specifically disclaims any obligation to update any forward-looking statements, whether as a result of new information, future events, or otherwise.

    For Media Inquiries:

    Christine Drury

    Director of Corporate Communications

    Syra Health

    463-345-5180

    [email protected]

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/syra-health-selected-for-5-8-million-indiana-child-mental-health-program-302465759.html

    SOURCE Syra Health

    Get the next $SYRA alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $SYRA

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $SYRA
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Director Reddy Vijayapal

    4 - Syra Health Corp (0001922335) (Issuer)

    11/25/25 7:15:14 PM ET
    $SYRA
    Diversified Commercial Services
    Consumer Discretionary

    SEC Form 4 filed by Director Paranjape Ketan

    4 - Syra Health Corp (0001922335) (Issuer)

    11/25/25 7:12:56 PM ET
    $SYRA
    Diversified Commercial Services
    Consumer Discretionary

    SEC Form 4 filed by Director Reddy Avutu

    4 - Syra Health Corp (0001922335) (Issuer)

    11/25/25 7:09:30 PM ET
    $SYRA
    Diversified Commercial Services
    Consumer Discretionary

    $SYRA
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Syra Health Announces Third Quarter Financial Results: Margins, Profitability Metrics Improve

    Q3 2025 Revenue of $1.7 MillionRevenue driven by 96% year-over-year growth in the Population Health segmentGross margin improved 300 basis points to 33% in Q3 2025 from 30% in Q3 2024Net loss decreased 46% year-over-yearEarnings per share improved to ($0.02) for Q3 2025 compared to ($0.6) for Q3 2024CARMEL, Ind., Nov. 12, 2025 /PRNewswire/ -- Syra Health Corp. (OTCQB:SYRA) ("Syra Health" or the "Company"), a healthcare solutions company dedicated to powering better health outcomes through prevention-focused, accessible, and affordable solutions, announced today its financial results for the third quarter ended September 30, 2025.

    11/12/25 7:55:00 AM ET
    $SYRA
    Diversified Commercial Services
    Consumer Discretionary

    Syra Health To Announce Third Quarter 2025 Financial Results

    CARMEL, Ind., Nov. 5, 2025 /PRNewswire/ -- Syra Health Corp. (OTCQB:SYRA), ("Syra Health" or the "Company"), a healthcare solutions company powering better health outcomes through innovative services and technology, announced today that it will report financial results for the three months ended September 30, 2025, on Wednesday, November 12, 2025. The results will be shared via press release before the market opens. About Syra Health Syra Health is a healthcare solutions company serving public and private healthcare organizations with innovative solutions that positively impac

    11/5/25 8:55:00 AM ET
    $SYRA
    Diversified Commercial Services
    Consumer Discretionary

    Syra Health to Participate in Two Upcoming Indiana Healthcare Conferences

    CARMEL, Ind., Sept. 23, 2025 /PRNewswire/ -- Syra Health Corp. (OTCQB:SYRA) ("Syra Health" or the "Company"), a healthcare solutions company focused on improving health outcomes through innovative services and technology, announced today its participation in two Indiana healthcare conferences this fall: Indiana Public Health Association 2025 Annual ConferenceOctober 22, 2025 – Indianapolis, IndianaIndiana Hospital Association Annual MeetingNovember 4–5, 2025 – Indianapolis, IndianaAt both events, Syra Health leaders will be available to meet with healthcare executives, public

    9/23/25 7:55:00 AM ET
    $SYRA
    Diversified Commercial Services
    Consumer Discretionary

    $SYRA
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    CFO and COO Prasad Priya bought $13,257 worth of shares (14,448 units at $0.92) and sold $10,144 worth of shares (4,153 units at $2.44) (SEC Form 4)

    4 - Syra Health Corp (0001922335) (Issuer)

    9/13/24 9:10:53 AM ET
    $SYRA
    Diversified Commercial Services
    Consumer Discretionary

    $SYRA
    SEC Filings

    View All

    Syra Health Corp. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits

    8-K - Syra Health Corp (0001922335) (Filer)

    11/18/25 4:05:51 PM ET
    $SYRA
    Diversified Commercial Services
    Consumer Discretionary

    Syra Health Corp. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

    8-K - Syra Health Corp (0001922335) (Filer)

    11/14/25 4:15:30 PM ET
    $SYRA
    Diversified Commercial Services
    Consumer Discretionary

    SEC Form 10-Q filed by Syra Health Corp.

    10-Q - Syra Health Corp (0001922335) (Filer)

    11/12/25 5:25:42 PM ET
    $SYRA
    Diversified Commercial Services
    Consumer Discretionary

    $SYRA
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Syra Health Corp.

    SC 13G - Syra Health Corp (0001922335) (Subject)

    2/20/24 3:01:17 PM ET
    $SYRA
    Diversified Commercial Services
    Consumer Discretionary

    $SYRA
    Leadership Updates

    Live Leadership Updates

    View All

    Syra Health Board Begins CEO Search to Drive Growth

    CARMEL, Ind., May 20, 2025 /PRNewswire/ -- Syra Health Corp. (OTCQB:SYRA) ("Syra Health" or the "Company"), a healthcare technology company dedicated to powering better health through innovative technology products and services, announced today that its Board of Directors will begin a national search for a new Chief Executive Officer to succeed current CEO Dr. Deepika Vuppalanchi. Dr. Vuppalanchi will serve as interim CEO until a successor is appointed. This leadership transition is part of a strategic succession plan designed to position Syra Health for its next phase of grow

    5/20/25 9:00:00 AM ET
    $SYRA
    Diversified Commercial Services
    Consumer Discretionary

    $SYRA
    Financials

    Live finance-specific insights

    View All

    Syra Health Announces First Quarter Revenue of $1.9 Million, Up 6% YoY

    Revenue increase led by Population Health's 261% YoY Expansion Gross Margin Improves Substantially to 31.7%, up 14.6 Percentage Points YoY Continued Efficiency Gains Cut Q1 2025 Net Losses by Over Two Thirds Compared to Q1 2024 A conference call will be held today, Thursday, May 8, at 9:00 am ET CARMEL, Ind., May 8, 2025 /PRNewswire/ -- Syra Health Corp. (OTCQB:SYRA) ("Syra Health" or the "Company"), a healthcare technology company dedicated to powering better health through innovative technology products and services, announced today its financial results for the first quarter ended March 31, 2025.

    5/8/25 7:55:00 AM ET
    $SYRA
    Diversified Commercial Services
    Consumer Discretionary

    Syra Health To Discuss First Quarter 2025 Financial Results

    Conference call will be held on Thursday, May 8, at 9:00 a.m. ET CARMEL, Ind., May 1, 2025 /PRNewswire/ -- Syra Health Corp. (OTCQB:SYRA), ("Syra Health" or the "Company"), a healthcare technology company dedicated to powering better health through innovative technology products and services, announced today that it will report financial results for the three months ended March 31, 2025, on Thursday, May 8, 2025, before market open. The Company will host a conference call that same day, May 8, 2025, at 9:00 a.m. ET, to discuss the results. Interested parties can access the con

    5/1/25 8:55:00 AM ET
    $SYRA
    Diversified Commercial Services
    Consumer Discretionary

    Syra Health Announces Full-Year Revenue of $8.0 Million, Up 45% YoY

    2024 Population Health Revenue Acceleration to 132% YoY Q4 2024 Net Losses Cut Nearly in Half Compared to Q4 2023, Highlighting Major Efficiency Gains Continued Momentum with New Customer Wins and Contract Extensions Driving Sustainable Growth A conference call will be held today, Tuesday, March 11 at 9:00 am ET CARMEL, Ind., March 11, 2025 /PRNewswire/ -- Syra Health Corp. (NASDAQ:SYRA) ("Syra Health" or the "Company"), a healthcare technology company dedicated to powering better health through innovative technology products and services, announced today its financial results for fourth quarter and full year ended December 31, 2024.

    3/11/25 7:43:00 AM ET
    $SYRA
    Diversified Commercial Services
    Consumer Discretionary